Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 10Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Tumor Burden × Clear all
NCT04257162 2025-09-09

HER2-PREDICT

SOLTI Breast Cancer Research Group

Phase NA Active not recruiting
180 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05953883 2025-03-04

PROGENITOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Active not recruiting
24 enrolled
Gynecologic

Ovarian Neoplasms

NCT04005820 2019-07-02

UMBRELLA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting
510 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡